aspirin has been researched along with Asymptomatic Conditions in 29 studies
Aspirin: The prototypical analgesic used in the treatment of mild to moderate pain. It has anti-inflammatory and antipyretic properties and acts as an inhibitor of cyclooxygenase which results in the inhibition of the biosynthesis of prostaglandins. Aspirin also inhibits platelet aggregation and is used in the prevention of arterial and venous thrombosis. (From Martindale, The Extra Pharmacopoeia, 30th ed, p5)
acetylsalicylate : A benzoate that is the conjugate base of acetylsalicylic acid, arising from deprotonation of the carboxy group.
acetylsalicylic acid : A member of the class of benzoic acids that is salicylic acid in which the hydrogen that is attached to the phenolic hydroxy group has been replaced by an acetoxy group. A non-steroidal anti-inflammatory drug with cyclooxygenase inhibitor activity.
Excerpt | Relevance | Reference |
---|---|---|
"Prospective cohort study as a secondary analysis of the Effects of Aspirin in Gestation and Reproduction randomized controlled trial of preconception-initiated low-dose aspirin among women with one or two prior pregnancy losses." | 9.34 | Physical activity and incidence of subclinical and clinical pregnancy loss: a secondary analysis in the effects of aspirin in gestation and reproduction randomized trial. ( Freeman, JR; Grewal, J; Mumford, SL; Perkins, NJ; Russo, LM; Schisterman, EF; Schliep, KC; Silver, RM; Sjaarda, LA; Whitcomb, BW, 2020) |
"Orchitis is characterized by acute or chronic testicular inflammation and is a primary cause of male infertility." | 5.62 | Aspirin Alleviates Particulate Matter Induced Asymptomatic Orchitis of Mice ( Chen, X; Ding, W; Jin, L; Lai, R; Liu, Y; Mwangi, J; Qiu, H; Zhao, L; Zhu, T, 2021) |
"Aspirin resistance was measured by the PFA-100 system (collagen/epinephrine cartridge) and glycoprotein IIIa P1A1/A2 polymorphism was determined by PCR." | 5.43 | Aspirin resistance in cerebrovascular disease and the role of glycoprotein IIIa polymorphism in Turkish stroke patients. ( Ataç, BF; Bayraktar, N; Can, U; Çelikkol, C; Derle, E; Kibaroğlu, S; Öcal, R; Verdi, H, 2016) |
"Prospective cohort study as a secondary analysis of the Effects of Aspirin in Gestation and Reproduction randomized controlled trial of preconception-initiated low-dose aspirin among women with one or two prior pregnancy losses." | 5.34 | Physical activity and incidence of subclinical and clinical pregnancy loss: a secondary analysis in the effects of aspirin in gestation and reproduction randomized trial. ( Freeman, JR; Grewal, J; Mumford, SL; Perkins, NJ; Russo, LM; Schisterman, EF; Schliep, KC; Silver, RM; Sjaarda, LA; Whitcomb, BW, 2020) |
"Semi-structured interviews with people who were eligible but had declined to participate in the Aspirin for Asymptomatic Atherosclerosis (AAA) trial (N = 11), and AAA trial participants who had stopped taking the trial medication (N = 11)." | 5.15 | Accrual and drop out in a primary prevention randomised controlled trial: qualitative study. ( Cunningham-Burley, S; Eborall, HC; Fowkes, FG; Price, JF; Stewart, MC, 2011) |
" Data from one randomised controlled trial showed no significant difference in benefit with aspirin versus placebo in asymptomatic carotid stenosis, but it is still reasonable to recommend aspirin (81-325 mg daily) for prevention of vascular events in these patients." | 5.01 | Optimal Antiplatelet Therapy in Moderate to Severe Asymptomatic and Symptomatic Carotid Stenosis: A Comprehensive Review of the Literature. ( de Borst, GJ; Halliday, A; Hamilton, G; Kakkos, S; McCabe, DJH; Murphy, SJX; Naylor, AR; Ricco, JB; Sillesen, H; Vega de Ceniga, M, 2019) |
"A case of asymptomatic eosinophilia in the setting of acetylsalicylic acid (aspirin) use was presented, followed by discussion of the clinical characteristics, diagnosis, and management of drug-induced eosinophilia." | 4.98 | Drug-induced eosinophilia. ( Freeman, A; Rauscher, C, 2018) |
" Of 2 treatment trials meeting inclusion criteria, 1 large trial (n = 3350) showed that low-dose aspirin did not prevent CVD events in persons with a screen-detected low ABI but may have increased the risk for major bleeding events." | 4.89 | The ankle-brachial index for peripheral artery disease screening and cardiovascular disease prediction among asymptomatic adults: a systematic evidence review for the U.S. Preventive Services Task Force. ( Johnson, ES; Lin, JS; Olson, CM; Whitlock, EP, 2013) |
"In the peripheral arteries, a thrombus superimposed on atherosclerosis contributes to the progression of peripheral artery disease (PAD), producing intermittent claudication (IC), ischemic necrosis, and, potentially, loss of the limb." | 2.50 | Systematic reviews and meta-analyses for more profitable strategies in peripheral artery disease. ( Cafaro, G; de Gaetano, G; Di Minno, A; Di Minno, G; Lupoli, R; Petitto, M; Spadarella, G; Tremoli, E, 2014) |
"Patients suffering from carotid artery stenosis symptomatic or not." | 2.48 | Carotid endarterectomy plus medical therapy or medical therapy alone for carotid artery stenosis in symptomatic or asymptomatic patients: a meta-analysis. ( Guay, J; Ochroch, EA, 2012) |
"Orchitis is characterized by acute or chronic testicular inflammation and is a primary cause of male infertility." | 1.62 | Aspirin Alleviates Particulate Matter Induced Asymptomatic Orchitis of Mice ( Chen, X; Ding, W; Jin, L; Lai, R; Liu, Y; Mwangi, J; Qiu, H; Zhao, L; Zhu, T, 2021) |
"It is a marker of atherosclerotic plaque burden and the strongest independent predictor of future myocardial infarction and mortality." | 1.46 | Cardiac Society of Australia and New Zealand position statement executive summary: coronary artery calcium scoring. ( Chan, J; Chow, CK; Hamilton-Craig, CR; Jelinek, VM; Liew, GY; Younger, JF, 2017) |
"All the patients presented with carotid artery stenosis >70% (North American Symptomatic Carotid Endarterectomy Trial [NASCET] criteria), which was symptomatic in 42 patients (transient ischemic attack, n = 32; minor stroke, n = 10) and asymptomatic in 146." | 1.46 | Dual Antiplatelet Therapy Does Not Increase the Risk of Bleeding After Carotid Endarterectomy: Results of a Prospective Study. ( Calio', FG; Illuminati, G; Masci, F; Pizzardi, G; Ricco, JB; Schneider, F, 2017) |
"Aspirin resistance was measured by the PFA-100 system (collagen/epinephrine cartridge) and glycoprotein IIIa P1A1/A2 polymorphism was determined by PCR." | 1.43 | Aspirin resistance in cerebrovascular disease and the role of glycoprotein IIIa polymorphism in Turkish stroke patients. ( Ataç, BF; Bayraktar, N; Can, U; Çelikkol, C; Derle, E; Kibaroğlu, S; Öcal, R; Verdi, H, 2016) |
"In the Asymptomatic Carotid Artery Stenosis trial (1995), medical management was defined as aspirin in addition to adequate control of comorbidities." | 1.39 | Efficacy of contemporary medical management for asymptomatic carotid artery stenosis. ( Ahn, JE; Chang, J; Chun, L; Landsman, N; Patel, KK; Rhee, K, 2013) |
"Aspirin is a widely used medication for primary and secondary prevention of cardiovascular and cerebrovascular events." | 1.39 | The prevalence of gastroduodenal mucosal injuries in aspirin users. ( Thongbai, T, 2013) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (3.45) | 29.6817 |
2010's | 25 (86.21) | 24.3611 |
2020's | 3 (10.34) | 2.80 |
Authors | Studies |
---|---|
Zhu, T | 1 |
Chen, X | 1 |
Qiu, H | 1 |
Liu, Y | 1 |
Mwangi, J | 1 |
Zhao, L | 1 |
Ding, W | 1 |
Lai, R | 1 |
Jin, L | 1 |
Chang, CC | 1 |
Spitzer, E | 1 |
Chichareon, P | 1 |
Takahashi, K | 1 |
Modolo, R | 1 |
Kogame, N | 1 |
Tomaniak, M | 1 |
Komiyama, H | 1 |
Yap, SC | 1 |
Hoole, SP | 1 |
Gori, T | 1 |
Zaman, A | 1 |
Frey, B | 1 |
Ferreira, RC | 1 |
Bertrand, OF | 1 |
Koh, TH | 1 |
Sousa, A | 1 |
Moschovitis, A | 1 |
van Geuns, RJ | 1 |
Steg, PG | 1 |
Hamm, C | 1 |
Jüni, P | 1 |
Vranckx, P | 1 |
Valgimigli, M | 1 |
Windecker, S | 1 |
Serruys, PW | 1 |
Soliman, O | 1 |
Onuma, Y | 1 |
Russo, LM | 1 |
Whitcomb, BW | 1 |
Freeman, JR | 1 |
Mumford, SL | 1 |
Sjaarda, LA | 1 |
Perkins, NJ | 1 |
Schliep, KC | 1 |
Grewal, J | 1 |
Silver, RM | 1 |
Schisterman, EF | 1 |
Hamilton-Craig, CR | 1 |
Chow, CK | 1 |
Younger, JF | 1 |
Jelinek, VM | 1 |
Chan, J | 1 |
Liew, GY | 1 |
Rauscher, C | 1 |
Freeman, A | 1 |
Guirguis-Blake, JM | 1 |
Evans, CV | 1 |
Redmond, N | 1 |
Lin, JS | 2 |
Curry, SJ | 1 |
Krist, AH | 1 |
Owens, DK | 1 |
Barry, MJ | 1 |
Caughey, AB | 1 |
Davidson, KW | 1 |
Doubeni, CA | 1 |
Epling, JW | 1 |
Kemper, AR | 1 |
Kubik, M | 1 |
Landefeld, CS | 1 |
Mangione, CM | 1 |
Silverstein, M | 1 |
Simon, MA | 1 |
Tseng, CW | 1 |
Wong, JB | 1 |
Murphy, SJX | 1 |
Naylor, AR | 1 |
Ricco, JB | 2 |
Sillesen, H | 1 |
Kakkos, S | 1 |
Halliday, A | 1 |
de Borst, GJ | 1 |
Vega de Ceniga, M | 1 |
Hamilton, G | 1 |
McCabe, DJH | 1 |
de Havenon, A | 1 |
Meyer, C | 1 |
McNally, JS | 1 |
Alexander, M | 1 |
Chung, L | 1 |
Conrad, MF | 3 |
Boulom, V | 1 |
Baloum, V | 1 |
Mukhopadhyay, S | 1 |
Garg, A | 1 |
Patel, VI | 2 |
Cambria, RP | 2 |
Olson, CM | 1 |
Johnson, ES | 1 |
Whitlock, EP | 1 |
Moyer, VA | 1 |
Chang, J | 1 |
Ahn, JE | 1 |
Landsman, N | 1 |
Rhee, K | 1 |
Chun, L | 1 |
Patel, KK | 1 |
Bakri, SJ | 1 |
Luqman, A | 1 |
Pathik, B | 1 |
Chandrasekaran, K | 1 |
Thongbai, T | 1 |
Alcocer, F | 1 |
Novak, Z | 1 |
Combs, BR | 1 |
Lowman, B | 1 |
Passman, MA | 1 |
Mujib, M | 1 |
Jordan, WD | 1 |
Michalczyk, MJ | 1 |
Opalacz, A | 1 |
LaMuraglia, GM | 1 |
Di Minno, G | 2 |
Spadarella, G | 1 |
Cafaro, G | 1 |
Petitto, M | 1 |
Lupoli, R | 1 |
Di Minno, A | 1 |
de Gaetano, G | 1 |
Tremoli, E | 1 |
Argulian, E | 1 |
Conen, D | 1 |
Messerli, FH | 1 |
Derle, E | 1 |
Öcal, R | 1 |
Kibaroğlu, S | 1 |
Çelikkol, C | 1 |
Bayraktar, N | 1 |
Verdi, H | 1 |
Ataç, BF | 1 |
Can, U | 1 |
Jones, DW | 1 |
Goodney, PP | 1 |
Nolan, BW | 1 |
Rzucidlo, EM | 1 |
Powell, RJ | 1 |
Cronenwett, JL | 1 |
Stone, DH | 1 |
Illuminati, G | 1 |
Schneider, F | 1 |
Pizzardi, G | 1 |
Masci, F | 1 |
Calio', FG | 1 |
Shankarappa, RK | 1 |
Panneerselvam, A | 1 |
Dwarakaprasad, R | 1 |
Karur, S | 1 |
Krishnanaik, GB | 1 |
Nanjappa, MC | 1 |
Tufano, A | 1 |
Guida, A | 1 |
Cerbone, AM | 1 |
Eborall, HC | 1 |
Stewart, MC | 1 |
Cunningham-Burley, S | 1 |
Price, JF | 1 |
Fowkes, FG | 1 |
Guay, J | 1 |
Ochroch, EA | 1 |
Dua, V | 1 |
Yadav, SP | 1 |
Kumar, V | 1 |
Saxena, R | 1 |
Sachdeva, A | 1 |
Spence, JD | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
The Effects of Aspirin in Gestation and Reproduction: A Multi-center, Controlled, Double-blind Randomized Trial.[NCT00467363] | 1,228 participants (Actual) | Interventional | 2007-06-30 | Completed | |||
Health Program for prEvention of cardiovascuLar disEases Based on a Risk screeNing Strategy With Ankle-brachial Index.[NCT05884840] | 54,000 participants (Anticipated) | Interventional | 2023-11-20 | Recruiting | |||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
Partial or complete abruption (ie, premature separation of the placenta) (NCT00467363)
Timeframe: until delivery
Intervention | participants (Number) |
---|---|
Aspirin | 7 |
Placebo | 5 |
(NCT00467363)
Timeframe: 8-weeks
Intervention | pregnancy (Number) |
---|---|
Aspirin | 374 |
Placebo | 346 |
Implantation failures (NCT00467363)
Timeframe: 8 weeks
Intervention | pregnancy (Number) |
---|---|
Aspirin | 28 |
Placebo | 27 |
(NCT00467363)
Timeframe: within 6 weeks
Intervention | pregnancy (Number) |
---|---|
Aspirin | 3 |
Placebo | 3 |
(NCT00467363)
Timeframe: until 40 weeks
Intervention | pregnancy (Number) |
---|---|
Aspirin | 4 |
Placebo | 6 |
(NCT00467363)
Timeframe: within 8-weeks of gestation
Intervention | pregnancy (Number) |
---|---|
Aspirin | 394 |
Placebo | 363 |
Live birth was obtained prospectively by maternal report and abstraction from medical records by trained staff . (NCT00467363)
Timeframe: after delivery
Intervention | livebirths (Number) |
---|---|
Aspirin | 309 |
Placebo | 286 |
(NCT00467363)
Timeframe: 8 weeks
Intervention | pregnancy (Number) |
---|---|
Aspirin | 0 |
Placebo | 0 |
(NCT00467363)
Timeframe: until delivery
Intervention | participants (Number) |
---|---|
Aspirin | 32 |
Placebo | 30 |
Includes preembryonic and embryonic losses (exclusive of implantation failures) (NCT00467363)
Timeframe: less than 10-weeks
Intervention | pregnancy (Number) |
---|---|
Aspirin | 56 |
Placebo | 53 |
(NCT00467363)
Timeframe: until delivery
Intervention | infants (Number) |
---|---|
Aspirin | 22 |
Placebo | 31 |
birthweight (NCT00467363)
Timeframe: until delivery
Intervention | grams (Mean) |
---|---|
Aspirin | 3327 |
Placebo | 3315 |
(NCT00467363)
Timeframe: 40 weeks
Intervention | participants (Number) |
---|---|
Aspirin | 2 |
Placebo | 2 |
8 reviews available for aspirin and Asymptomatic Conditions
Article | Year |
---|---|
Drug-induced eosinophilia.
Topics: Adult; Allergens; Aspirin; Asymptomatic Diseases; Cardiomyopathies; Drug Hypersensitivity; Eosinophi | 2018 |
Screening for Peripheral Artery Disease Using the Ankle-Brachial Index: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force.
Topics: Ankle Brachial Index; Aspirin; Asymptomatic Diseases; Early Diagnosis; Exercise Therapy; Fibrinolyti | 2018 |
Optimal Antiplatelet Therapy in Moderate to Severe Asymptomatic and Symptomatic Carotid Stenosis: A Comprehensive Review of the Literature.
Topics: Aspirin; Asymptomatic Diseases; Carotid Stenosis; Clopidogrel; Dipyridamole; Drug Therapy, Combinati | 2019 |
Subclinical Cerebrovascular Disease: Epidemiology and Treatment.
Topics: Aged; Aged, 80 and over; Aspirin; Asymptomatic Diseases; Brain Infarction; Dementia; Female; Humans; | 2019 |
The ankle-brachial index for peripheral artery disease screening and cardiovascular disease prediction among asymptomatic adults: a systematic evidence review for the U.S. Preventive Services Task Force.
Topics: Adult; Ankle Brachial Index; Aspirin; Asymptomatic Diseases; Cardiovascular Diseases; Fibrinolytic A | 2013 |
Systematic reviews and meta-analyses for more profitable strategies in peripheral artery disease.
Topics: Adenosine; Aspirin; Asymptomatic Diseases; Cilostazol; Clopidogrel; Fibrinolytic Agents; Humans; Int | 2014 |
Misconceptions and Facts About Atrial Fibrillation.
Topics: Administration, Oral; Alcohol Drinking; Anticoagulants; Aspirin; Asymptomatic Diseases; Atrial Fibri | 2015 |
Carotid endarterectomy plus medical therapy or medical therapy alone for carotid artery stenosis in symptomatic or asymptomatic patients: a meta-analysis.
Topics: Aspirin; Asymptomatic Diseases; Carotid Stenosis; Endarterectomy, Carotid; Humans; Life Style; Rando | 2012 |
3 trials available for aspirin and Asymptomatic Conditions
Article | Year |
---|---|
Ascertainment of Silent Myocardial Infarction in Patients Undergoing Percutaneous Coronary Intervention (from the GLOBAL LEADERS Trial).
Topics: Aged; Analysis of Variance; Aspirin; Asymptomatic Diseases; Coronary Angiography; Drug Therapy, Comb | 2019 |
Physical activity and incidence of subclinical and clinical pregnancy loss: a secondary analysis in the effects of aspirin in gestation and reproduction randomized trial.
Topics: Abortion, Spontaneous; Adolescent; Adult; Aspirin; Asymptomatic Diseases; Cohort Studies; Exercise; | 2020 |
Accrual and drop out in a primary prevention randomised controlled trial: qualitative study.
Topics: Aged; Aspirin; Asymptomatic Diseases; Atherosclerosis; Cardiovascular Agents; Female; Focus Groups; | 2011 |
18 other studies available for aspirin and Asymptomatic Conditions
Article | Year |
---|---|
Aspirin Alleviates Particulate Matter Induced Asymptomatic Orchitis of Mice
Topics: Acetylation; Air Pollutants; Animals; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Asymptomatic | 2021 |
Screening for Asymptomatic Carotid Artery Stenosis: Recommendation Statement.
Topics: Aged; Aspirin; Asymptomatic Diseases; Cardiovascular Diseases; Carotid Stenosis; Health Behavior; He | 2021 |
Cardiac Society of Australia and New Zealand position statement executive summary: coronary artery calcium scoring.
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Asymptomatic Diseases; Coronary Artery Disea | 2017 |
Screening for Peripheral Artery Disease and Cardiovascular Disease Risk Assessment With the Ankle-Brachial Index: US Preventive Services Task Force Recommendation Statement.
Topics: Adult; Ankle Brachial Index; Aspirin; Asymptomatic Diseases; Early Diagnosis; Exercise Therapy; Fibr | 2018 |
Progression of asymptomatic carotid stenosis despite optimal medical therapy.
Topics: Aged; Aged, 80 and over; Aspirin; Asymptomatic Diseases; Biomarkers; Cardiovascular Agents; Carotid | 2013 |
Screening for peripheral artery disease and cardiovascular disease risk assessment with the ankle-brachial index in adults: U.S. Preventive Services Task Force recommendation statement.
Topics: Adult; Ankle Brachial Index; Aspirin; Asymptomatic Diseases; Cardiovascular Diseases; Cost of Illnes | 2013 |
Efficacy of contemporary medical management for asymptomatic carotid artery stenosis.
Topics: Aged; Aged, 80 and over; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; | 2013 |
Is carotid ultrasound necessary in the evaluation of the asymptomatic Hollenhorst plaque?
Topics: Arterioles; Aspirin; Asymptomatic Diseases; Carotid Arteries; Carotid Stenosis; Endarterectomy, Caro | 2013 |
The prevalence of gastroduodenal mucosal injuries in aspirin users.
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Asymptomatic Diseases; Endoscopy, Gastrointe | 2013 |
Dual antiplatelet therapy (clopidogrel and aspirin) is associated with increased all-cause mortality after carotid revascularization for asymptomatic carotid disease.
Topics: Aged; Alabama; Angioplasty; Aspirin; Asymptomatic Diseases; Carotid Stenosis; Clopidogrel; Drug Ther | 2014 |
The natural history of asymptomatic severe carotid artery stenosis.
Topics: Aged; Aspirin; Asymptomatic Diseases; Blood Flow Velocity; Cardiovascular Agents; Carotid Stenosis; | 2014 |
Aspirin resistance in cerebrovascular disease and the role of glycoprotein IIIa polymorphism in Turkish stroke patients.
Topics: Age Factors; Aged; Aged, 80 and over; Aspirin; Asymptomatic Diseases; Blood Platelets; Drug Resistan | 2016 |
Dual antiplatelet therapy reduces stroke but increases bleeding at the time of carotid endarterectomy.
Topics: Aged; Aspirin; Asymptomatic Diseases; Carotid Artery Diseases; Chi-Square Distribution; Clopidogrel; | 2016 |
Dual Antiplatelet Therapy Does Not Increase the Risk of Bleeding After Carotid Endarterectomy: Results of a Prospective Study.
Topics: Aged; Aged, 80 and over; Anticoagulants; Aspirin; Asymptomatic Diseases; Carotid Stenosis; Clopidogr | 2017 |
Spontaneous asymptomatic coronary artery dissection in a young man.
Topics: Acute Coronary Syndrome; Adult; Age Factors; Aortic Dissection; Aspirin; Asymptomatic Diseases; Coro | 2009 |
The "antiphospholipid triangle" in an asymptomatic patient: a case report.
Topics: Antibodies, Anticardiolipin; Antiphospholipid Syndrome; Aspirin; Asymptomatic Diseases; beta 2-Glyco | 2010 |
Two cases of pediatric essential thrombocythemia managed effectively with hydroxyurea.
Topics: Aspirin; Asymptomatic Diseases; Bone Marrow; Child; Child, Preschool; Female; Headache; Humans; Hydr | 2012 |
Asymptomatic carotid stenosis.
Topics: Aged; Amlodipine; Anticholesteremic Agents; Aspirin; Asymptomatic Diseases; Atorvastatin; Azetidines | 2013 |